Aurora Cannabis Inc. (ACB) News
Follow Aurora Cannabis Inc. (ACB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 55 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Aurora Cannabis Announces Fiscal 2027 Second-Quarter Results
EQUITY | Nov 05, 2026, 02:33 PM UTC
M
Aurora Cannabis Adjusted Net Income Declines Year Over Year
Aurora Cannabis reported a year-over-year decline in adjusted net income for fiscal Q2 2027.
EARNINGS | Nov 05, 2026, 02:14 PM UTC
M
Aurora Cannabis Q2 Revenue Beats Estimates on International Demand
EQUITY | Nov 05, 2026, 12:48 PM UTC
M
Aurora Cannabis Reports Q2 Revenue of CA$86.0M
Aurora Cannabis reported Q2 revenue of CA$86.0 million, compared with a FactSet estimate of CA$71.4 million.
EQUITY | Nov 05, 2026, 12:16 PM UTC
M
Aurora Cannabis Reports Fiscal 2027 Second-Quarter Results
Aurora Cannabis announced results for the quarter ended September 30, 2026. The company also cancelled its scheduled investor call.
EQUITY | Nov 05, 2026, 12:05 PM UTC
M
Curaleaf Says Its Aurora Takeover Bid Still Stands After Rival Deal
Curaleaf said its offer to acquire Aurora Cannabis remains outstanding after Aurora accepted Organigram Global’s buyout offer.
MNA | Nov 03, 2026, 11:11 PM UTC
M
Organigram Agrees to Buy Aurora Cannabis for C$560 Million
Organigram agreed to acquire Aurora Cannabis for a total of C$560 million. The deal tops Curaleaf’s long-running hostile bid for Aurora.
MNA | Nov 03, 2026, 07:16 PM UTC
M
Transaction Values Aurora at Approximately C$561M
The transaction values Aurora at approximately C$561 million on a fully diluted equity value basis.
MNA | Nov 03, 2026, 05:21 PM UTC
M
Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Share
EQUITY | Nov 03, 2026, 04:52 PM UTC
M
Organigram’s C$561 Million Offer Fends Off Curaleaf’s Hostile Aurora Bid
Organigram’s roughly C$561 million cash-and-stock offer for Aurora Cannabis at C$7.80 a share is agreed, compared with Curaleaf’s unsolicited C$6.45 bid. The offer represents a 21% premium over Curaleaf’s bid.
MNA | Nov 03, 2026, 04:21 PM UTC
M
Organigram to Acquire Aurora Cannabis in C$561 Million Deal
Aurora Cannabis agreed to be acquired by Organigram Global in a deal valued at C$561 million ($401.1 million), fending off a hostile bid from Curaleaf Holdings.
EQUITY | Nov 03, 2026, 02:51 PM UTC
L
Trading Resumes in Aurora Cannabis
Trading in Aurora Cannabis (ACB) has resumed on the TSX.
EQUITY | Nov 03, 2026, 02:41 PM UTC
M
Transaction Values Aurora at About C$561M on Fully Diluted Basis
MNA | Nov 03, 2026, 02:18 PM UTC
M
Organigram to Acquire Aurora for C$7.80 per Share
Organigram will acquire Aurora for C$7.80 per Aurora common share.
EQUITY | Nov 03, 2026, 02:18 PM UTC
M
CIRO halts trading in ACB
CIRO says trading in Aurora Cannabis shares has been halted.
EQUITY | Nov 03, 2026, 01:47 PM UTC
L
ACB: trading halted on Nasdaq — news pending (8:25 AM ET)
Nasdaq halted trading in ACB (news pending) at 8:25 AM ET.
EQUITY | Nov 03, 2026, 01:25 PM UTC
M
Alberta Securities Commission Dismisses Curaleaf Application on Aurora ATM Program
The Alberta Securities Commission dismissed Curaleaf’s application and ruled in favour of Aurora Cannabis’s at-the-market program.
REGULATION | Oct 26, 2026, 12:48 PM UTC
M
Aurora Urges Shareholders to Reject Curaleaf’s Revised Hostile Bid
Aurora Cannabis says its board reconfirmed its recommendation that shareholders reject Curaleaf’s revised hostile bid.
MNA | Oct 14, 2026, 07:50 PM UTC
M
Curaleaf Files Sweetened $324.2M Offer for Aurora Cannabis
Curaleaf Holdings has officially filed its increased takeover offer for Aurora Cannabis in a bid to force transaction talks and test whether competing offers will emerge.
MNA | Oct 06, 2026, 04:40 PM UTC
M
Curaleaf Sweetens Aurora Cannabis Offer to $324.2M
Curaleaf Holding has sweetened its offer for Aurora Cannabis to $324.2 million, aiming to attract institutional investors and initiate negotiations.
EQUITY | Oct 05, 2026, 10:43 PM UTC
M
Aurora Cannabis Shares Rise on Sweetened Curaleaf Takeover Offer
Aurora Cannabis shares surged Monday after Curaleaf Holdings boosted its hostile takeover offer. Under the revised terms, Aurora shareholders would receive...
MNA | Oct 05, 2026, 02:41 PM UTC
H
Curaleaf raises Aurora Cannabis takeover offer to $324.2 million
Curaleaf Holdings has increased its hostile takeover offer for Canadian cannabis producer Aurora Cannabis to $324.2 million, or $5.00 a share, in an effort to pressure Aurora's board into negotiations. The new offer incl
EQUITY | Oct 05, 2026, 12:43 PM UTC
M
Curaleaf Increases Cash Consideration to $1 Per Aurora Share
Curaleaf has increased its cash consideration by 33% to $1 per Aurora share.
MNA | Oct 05, 2026, 12:02 PM UTC
L
Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB
Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB
NEWS | Sep 23, 2026, 10:30 PM UTC
L
Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws
Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws
NEWS | Sep 23, 2026, 10:30 PM UTC
L
ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NEWS | Sep 23, 2026, 10:29 PM UTC
L
Aurora Cannabis Inc. (ACB) Seeks ASC Order on Curaleaf Bid Disclosures
Aurora filed an application with the Alberta Securities Commission alleging deficiencies in Curaleaf’s hostile bid circular and seeks corrections and a full 105-day deposit period.Material DetailsContext by AI AnalystThi
NEWS | Sep 23, 2026, 10:29 PM UTC
L
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
NASDAQ | TSX:ACBEDMONTON, AB, Sept. 23, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today filed an application with t
NEWS | Sep 23, 2026, 10:29 PM UTC
H
Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA
Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute incremental net reven
LIVE | Sep 16, 2026, 11:07 AM UTC
M
Aurora Cannabis reaffirms FY27 Q2 guidance for sequential quarterly revenue
Aurora Cannabis re-affirms its FY27 2Q guidance, citing sequential growth in quarterly net revenue.
EQUITY | Sep 16, 2026, 11:06 AM UTC
L
ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond
MNA | Sep 16, 2026, 11:05 AM UTC
L
ACB appoints biopharmaceutical executive to lead medical cannabis commercial acceleration
Aurora Cannabis (ACB) appoints a seasoned biopharmaceutical executive to lead commercial acceleration of its global medical cannabis business.
EQUITY | Sep 09, 2026, 11:06 AM UTC
L
Aurora Cannabis appoints Faris El Refaie to lead global commercial push
Aurora Cannabis says biopharmaceutical executive Faris El Refaie, with 25 years of experience, will join as Executive Vice President for Global Commercial operations.
EQUITY | Sep 09, 2026, 11:05 AM UTC
H
Bank of Canada keeps policy rate steady at 2.25%
Bank of Canada left its main interest rate unchanged at 2.25% and took a more alarmed tone on upside inflation risks tied to new cross-border tariffs and no imminent end to the war in the Middle East.
CENTRAL_BANK | Sep 02, 2026, 08:32 PM UTC
M
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis urged shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, saying it is inadequate and undervalues parts of Aurora’s business.
MNA | Sep 02, 2026, 04:24 PM UTC
L
Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us'
Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us'
EQUITY | Sep 02, 2026, 03:20 PM UTC
L
ACB responds to Aurora circular, reiterates best value path
ACB responded to an Aurora circular and reaffirmed its offer as the best path to value creation for shareholders.
EQUITY | Sep 02, 2026, 03:18 PM UTC
L
Curaleaf offer undervalues Aurora medical business, CEO says
Curaleaf’s offer is seen as undervaluing Aurora’s medical cannabis business, according to the CEO.
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis open to different offers, CEO says
Aurora Cannabis says it remains open to different offers, per its CEO.
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T
Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T
EQUITY | Sep 02, 2026, 02:45 PM UTC
L
Aurora Cannabis CEO says Curaleaf bid undervalues business
Aurora Cannabis CEO Miguel Martin said Curaleaf's bid undervalues the business.
EQUITY | Sep 02, 2026, 02:45 PM UTC
H
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis is urging shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, calling it inadequate and aimed at using Aurora’s clean balance sheet to absorb Curaleaf’s heavy debt l
MNA | Sep 02, 2026, 12:41 PM UTC
L
Aurora Cannabis urges shareholders to reject Curaleaf takeover bid
Aurora Cannabis says its board is unanimous in urging shareholders to reject Curaleaf Holdings’ unsolicited takeover bid, calling it an undervaluation of Aurora’s current business and future potential.
MNA | Sep 02, 2026, 11:56 AM UTC
L
Aurora Cannabis says Curaleaf bid undervalues company
Aurora Cannabis said Curaleaf’s bid undervalues the company.
EQUITY | Sep 02, 2026, 11:08 AM UTC
M
Aurora Cannabis urges shareholders to reject Curaleaf hostile bid
Aurora Cannabis says Curaleaf’s hostile bid is inadequate, undervalues Aurora, and risks shareholder value and future upside.
EQUITY | Sep 02, 2026, 11:05 AM UTC
L
ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
EQUITY | Aug 24, 2026, 07:46 PM UTC
L
Aurora Cannabis special committee has not yet recommended Curaleaf offer
Aurora Cannabis says its special committee of the board has not yet made a formal recommendation regarding the Curaleaf offer.
MNA | Aug 24, 2026, 11:10 AM UTC
L
Aurora Cannabis corrects statements supporting Curaleaf hostile bid
Aurora Cannabis says it is correcting inaccurate statements made in support of Curaleaf Holdings' hostile bid.
MNA | Aug 24, 2026, 11:06 AM UTC
M
Aurora Cannabis acquires Internode Pharma and HAP Pharma
Aurora Cannabis says it is acquiring Internode Pharma Limited and HAP Pharma Limited to expand distribution access to the UK medical cannabis market.
MNA | Aug 19, 2026, 05:46 PM UTC
H
Aurora Cannabis urges no action on Curaleaf unsolicited bid
Aurora Cannabis (ACB) urges shareholders to take no action at this time regarding Curaleaf Holdings’ unsolicited take-over bid.
MNA | Aug 19, 2026, 11:06 AM UTC
L
Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times
EQUITY | Aug 11, 2026, 08:15 PM UTC
L
Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Bel
Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Below December 2025 Trading Levels
EQUITY | Aug 11, 2026, 07:28 PM UTC
H
Aurora Cannabis Responds To Curaleaf Takeover Bid
Aurora Cannabis responds to Curaleaf's intention to launch an unsolicited takeover bid
MNA | Aug 11, 2026, 07:23 PM UTC
L
ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results
ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results
EARNINGS | Aug 05, 2026, 11:02 AM UTC
L
ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility
ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility
EQUITY | Jul 23, 2026, 11:17 AM UTC